7-11 March, 2025
Orlando, FL
Thank you for Connecting with us at AAD Annual Meeting 2025
Lambda & Novum participated in AAD Annual Meeting 2025, held from March 7-11, 2025, in Orlando, FL. We appreciate the opportunity to have engaged with industry leaders and showcased our extensive experience in drug development.
As a Trusted CRO Partner, Lambda & Novum delivers comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide. With a focus on secure IT infrastructure and automation, Lambda ensures timely project delivery and strict adherence to global regulatory standards. Our exemplary regulatory track record includes over 60 successful international inspections and audits by esteemed authorities such as the USFDA, EMEA, MHRA, EU member states, and other global bodies over the past five years.
Lambda’s commitment to excellence has garnered significant recognition, including the ‘Best Indian CRO’ award from Frost & Sullivan (USA) and the ‘Great Indian Workplace’ title from UBS Transformance. Recent accolades include the ‘Regulatory Excellence’ Award at the CPhI Pharma Awards 2023 and the ‘Industry Partner of the Year’ Award at the Global Generics & Biosimilar Awards 2023.
Explore how Lambda & Novum’s full-service CRO capabilities can support your dermatology clinical development at every stage. With experience in over 105 dermatology studies across diverse indications, enrolling 42,000+ patients across 1,400+ sites, we are equipped to accelerate your dermatology research. We look forward to showcasing how our extensive experience and expertise in drug development can drive your project’s success. Please fill out the form on the right or drop us a line at bd@novumprs.com, and we will get in touch with you promptly.
